Quadax Blog Archives - Page 3 of 13 - Quadax

Leveraging AI to Tackle Staffing Challenges in 2025

Posted on December 2, 2024December 2, 2024

Leveraging AI to Tackle Staffing Challenges in 2025

How utilizing AI and Predictive Intelligence can help solve RCM workforce woes

Overcoming UHC Denials for Multiple Units of 88342 and 88341

Posted on November 6, 2024November 6, 2024

Overcoming UHC Denials for Multiple Units of 88342 and 88341

Adhering to UHC’s MUE guidelines, improving documentation, and reviewing appeals can help pathology labs boost reimbursement.

Key Updates in Medicare’s 2025 Physician Fee Schedule Final Rule

Posted on November 6, 2024November 6, 2024

Key Updates in Medicare's 2025 Physician Fee Schedule Final Rule

The 2025 CMS PFS final rule is set to impact healthcare providers. Learn about the reimbursement changes and how they might affect your practice.

Building Successful Lab-Payer Partnerships: The Market Access Dating Game

Posted on October 15, 2024October 15, 2024

Similar to dating, laboratories need to synchronize their objectives and motivations with payers to form effective partnerships.

Turning Adversity into Action: Why Superior Service Matters in Times of Crisis

Posted on September 12, 2024September 12, 2024

Why a proactive approach is vital during critical times and key aspects to consider when choosing a reliable revenue cycle vendor.

How UnitedHealthcare’s Gold Card Program Simplifies Prior Authorization

Posted on September 9, 2024September 9, 2024

The country’s largest commercial health insurer revealed details about its new program aimed at reducing unnecessary costs.

Unlocking Success: Early-Stage Lab Commercialization Checklist

Posted on August 20, 2024August 20, 2024

Careful planning and strategic collaboration with a revenue cycle partner are essential for a successful kickoff to the commercialization process.

Maximizing Revenue Cycle Efficiency with Expected Reimbursement Strategies

Posted on August 15, 2024August 19, 2024

Integrating expected reimbursement into RCM software enables real-time comparisons and automates denial management for effective AR oversight.

Optimizing Denial Management and Workflows for Revenue Cycle Success

Posted on August 12, 2024August 19, 2024

Three strategies for streamlined operations, reduced burdens, and improved financial stability.

FDA’s New LDT Rule Unveiled: Key Insights and Lab Preparations

Posted on June 11, 2024September 19, 2024

Prepare for compliance and explore alternatives to mitigate regulatory burdens amidst legislative and legal challenges.